Citius Pharmaceuticals, Inc. (CTXR) Shareholders’ equity 2017–2022
Citius Pharmaceuticals, Inc. (CTXR) shareholders’ equity at each fiscal year-end, per SEC filings.
$102.8MFY2022 · since FY2017: $21.9M → $102.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $102.8M | -22.2% |
| FY2021 | $132.2M | +292.6% |
| FY2020 | $33.7M | +24.0% |
| FY2019 | $27.2M | -11.4% |
| FY2018 | $30.6M | +39.6% |
| FY2017 | $21.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice